| ALMIRALL S.A. | 11,6300 / -0,94% |
| 日付/時刻 | 15.01. / 17:35 |
| 変化 / 変化(%) | -0,1100 / -0,94% |
| Bid | 11,4600 / 300 |
| Ask | 11,7300 / 150 |
| 始値 | 11,7400 |
| 直前終値 | 11,7400 |
| 高値 | 11,7400 |
| 安値 | 11,4800 |
| 出来高 [EUR] | 4.017.068,5200 |
| 出来高 [Units] | 357.052 |
| Price fixings | 1409 |
| ISIN | ES0157097017 |
| シンボル | ALM |
| 取引所 | Madrid |
| 種類 | 株式 |
すべての取引所
| 取引所 | 直近 | 出来高 | |
|---|---|---|---|
| Madrid | 11,6300 |  |
357.052 |
| Cboe Europe .. | 11,60 |  |
47.049 |
| Turquoise | 11,61 | |
21.739 |
| London Inter.. | 11,55 | |
12.392 |
| TradeGate | 11,57 | |
40 |
| Frankfurt | 11,7000 | |
0 |
| Berlin | 11,700 | |
0 |
| Stuttgart | 11,500 | |
0 |
| Lang & Schwa.. | 11,470 | |
|
| Cboe Europe .. | 11,76 | 1.759 | |
| Cboe Europe .. | 11,14 | 877 | |
| Nasdaq Other.. | 12,4000 | 1.087 |
ニュース
- Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
06.01.2021 / 14:00 - GlobeNewswire - Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
04.01.2021 / 23:00 - GlobeNewswire - Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
15.12.2020 / 13:00 - GlobeNewswire - Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
08.12.2020 / 14:13 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01.12.2020 / 22:05 - GlobeNewswire